Eligibility criteria for Tenofovir AF/Emtricitabine (Descovy®) for pre-exposure prophylaxis for HIV (PrEP) in Scotland
- Type
- Guidance
- Published
- 20 December 2022
- Sexual health
Description
This is a clinical guidance document for clinicians and prescribers to aid decision-making and cost-sensitive prescribing.
Files
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.